Seguir
Zohar Weinstein
Zohar Weinstein
Boston University School of Medicine
Dirección de correo verificada de bu.edu
Título
Citado por
Citado por
Año
Systematic exploration of synergistic drug pairs
M Cokol, HN Chua, M Tasan, B Mutlu, ZB Weinstein, Y Suzuki, ME Nergiz, ...
Molecular systems biology 7 (1), 544, 2011
3472011
Adolescent initiation of licit and illicit substance use: impact of intrauterine exposures and post-natal exposure to violence
DA Frank, R Rose-Jacobs, D Crooks, HJ Cabral, J Gerteis, KA Hacker, ...
Neurotoxicology and teratology 33 (1), 100-109, 2011
752011
Controlling uncertainty in aptamer selection
F Spill, ZB Weinstein, A Irani Shemirani, N Ho, D Desai, MH Zaman
Proceedings of the National Academy of Sciences 113 (43), 12076-12081, 2016
602016
Results of a statewide survey of adolescent substance use screening rates and practices in primary care
SK Harris, K Herr-Zaya, Z Weinstein, K Whelton, F Perfas Jr, ...
Substance abuse 33 (4), 321-326, 2012
562012
Evolution of rifampin resistance in Escherichia coli and Mycobacterium smegmatis due to substandard drugs
ZB Weinstein, MH Zaman
Antimicrobial agents and chemotherapy 63 (1), 10.1128/aac. 01243-18, 2019
462019
Prediction of antibiotic interactions using descriptors derived from molecular structure
DJ Mason, I Stott, S Ashenden, ZB Weinstein, I Karakoc, S Meral, N Kuru, ...
Journal of medicinal chemistry 60 (9), 3902-3912, 2017
422017
Physical mapping integrated with syntenic analysis to characterize the gene space of the long arm of wheat chromosome 1A
SJ Lucas, BA Akpınar, M Kantar, Z Weinstein, F Aydınoğlu, J Šafář, ...
PLoS One 8 (4), e59542, 2013
402013
Prediction of synergistic drug combinations
ZB Weinstein, A Bender, M Cokol
Current Opinion in Systems Biology 4, 24-28, 2017
392017
Target-independent prediction of drug synergies using only drug lipophilicity
K Yilancioglu, ZB Weinstein, C Meydan, A Akhmetov, I Toprak, A Durmaz, ...
Journal of chemical information and modeling 54 (8), 2286-2293, 2014
372014
Large-scale identification and analysis of suppressive drug interactions
M Cokol, ZB Weinstein, K Yilancioglu, M Tasan, A Doak, D Cansever, ...
Chemistry & biology 21 (4), 541-551, 2014
312014
Modeling the impact of drug interactions on therapeutic selectivity
ZB Weinstein, N Kuru, S Kiriakov, AC Palmer, AS Khalil, PA Clemons, ...
Nature communications 9 (1), 3452, 2018
242018
Quantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis
ZB Weinstein, MH Zaman
Scientific reports 7 (1), 42644, 2017
102017
Acceptability of drug testing in an outpatient substance abuse program for adolescents
S Levy, JR Knight, T Moore, Z Weinstein, L Sherritt, RD Weiss
Journal of adolescent health 48 (3), 229-233, 2011
92011
The Genotype and Phenotypes in Families (GPF) platform manages the large and complex data at SFARI
L Chorbadjiev, M Cokol, Z Weinstein, K Shi, C Fleisch, N Dimitrov, ...
bioRxiv, 2024.02. 08.579330, 2024
2024
Substandard antimicrobial drugs: detection methods and their contributions to antibiotic resistance
Z Weinstein
2020
Synergy and selectivity of antifungal small molecule combinations
Z Weinstein, N Kuru, P Clemons, F Roth, M Çokol
The FASEB Journal 29, 773.13, 2015
2015
A State-Wide Survey of Adolescent substance Use screening Rates and Practices in Primary Care
SK Harris, K Herr-Zaya, Z Weinstein, C Castro-Donlan, S Levy
SUBSTANCE ABUSE 32 (1), 66-66, 2011
2011
The Effect of Drug Testing in Reducing Drug Use by Adolescents with Substance Use Disorders
S Levy, S Van Hook, C Bridgemohan, Z Weinstein, S Kiley
SUBSTANCE ABUSE 32 (1), 66-66, 2011
2011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–18